Sildenafil (Viagra) in the treatment of male erectile dysfunction in Nairobi

East African Medical Journal

Volumn 77, Issue 2, 2000, Pages 76-79

  Magoha, G A O ^a  

^a UNIVERSITY OF NAIROBI   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP PHOSPHODIESTERASE; DRUG; PIPERAZINE DERIVATIVE; SILDENAFIL;

ADULT; AFRICA; AFRICA SOUTH OF THE SAHARA; AGED; ARTICLE; BEHAVIOR; BIOLOGY; CHEMICALLY INDUCED DISORDER; CLINICAL RESEARCH; CLINICAL TRIAL; DEVELOPING COUNTRY; DRUG ANTAGONISM; DRUG COST; DYSPEPSIA; EASTERN AFRICA; ECONOMICS; ENGLISH SPEAKING AFRICA; GENITAL EFFECTS, MALE; GENITAL SYSTEM; HEADACHE; HEALTH; HUMAN; IMPOTENCE; INCREASED LIBIDO--MEN; KENYA; MALE; MALE GENITAL SYSTEM; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RESEARCH REPORT; SEXUAL BEHAVIOR; STUDIES; TREATMENT; TREATMENT OUTCOME; UROGENITAL SYSTEM;

AFRICA; AFRICA SOUTH OF THE SAHARA; BEHAVIOR; BIOLOGY; CLINICAL RESEARCH; DEVELOPING COUNTRIES; DRUGS; EASTERN AFRICA; ENGLISH SPEAKING AFRICA; GENITAL EFFECTS, MALE; GENITALIA; GENITALIA, MALE; INCREASED LIBIDO--MEN; KENYA; MEN; PHYSIOLOGY; PROSPECTIVE STUDIES; RESEARCH METHODOLOGY; RESEARCH REPORT; SEX BEHAVIOR; STUDIES; TREATMENT; UROGENITAL SYSTEM;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; ADULT; AGED; AGED, 80 AND OVER; DRUG COSTS; DYSPEPSIA; HEADACHE; HUMANS; IMPOTENCE; KENYA; MALE; MIDDLE AGED; PIPERAZINES; PROSPECTIVE STUDIES; QUESTIONNAIRES; TREATMENT OUTCOME; URBAN HEALTH;

EID: 0034136340     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. NHI. Consensus development panel on impotence. J. Amer. Med. Ass. 1993; 270: 83-90.
2. Krane, R.J. Goldstein I. and Saenz de Tejada I. Impotence. N. Engl. J. Med. 1989; 321: 1648.
3. Feldman H.A., Goldstein, I. Haizichristou, D.G., Kraine R.J. and Mc Unley J.B. Impotence and its medical and psychosocial: Results of the Masachusetts male aging study. J. Urol. 1994; 151:54-61.
4. Plaud, J. Dubbert P.M., Lolm J. et al. Erectile dysfunction in men with chronic medical illness. J. Beh. Ther. Exp. Psychiat 1996; 27:11-19.
5. Morley, J. Impotence. Amer. J. Med. 1986; 80: 897-905.
6. Slag, M. Morley, J.E., Elson M.K. et al Impotence in medical clinic outpatients. J. Amer. Med. Ass. 1983; 249: 736-740.
7. Spark, R. White, R.A. and Connolly P.B. Impotence is not always psychogenic: Newer insights into hypothalamic pituitary gonadal dysfunction. J. Amer. Med. Ass. 1980; 1980: 750-755.
8. National institute of diabetes, digestive, kidney diseases. National kidney and urologic diseases information clearing house. NIH publishing NO. 95-3923, 1995.
9. Jevitch M.J. Edson N., Jarman W.D. et al Vascular factors in erectile failure in diabetics. Urology, 1982; 19: 163-168.
10. O'sullivan D.C., Munson K.W. and Chilton C.P. Impotence: First line treatment with vacuum device. J. Urol. 1994; 151: 347-349.
11. Baltaci, S., Aydos, K., Kosar et al. Treating erectile dysfunction with vacuum tumsense device: A retrospective analysis of acceptance and satisfaction. Brit. J. Urol. 1995; 76: 757-760.
12. Linet, O.I. and Ogrinc F.G. Efficacy and safely of intracavernosal alprostadil in men with erectile dysfunction. N. Engl. J. Med. 1996; 334: 873-877.
13. Padma-nathan, H. Hellstrom, W.J.G., Kaiser, F.E. et al. Treatment of men with erectile dysfunction with transurethral alprostadil. New. Engl. J. Med. 1997; 336: 1-7.
14. Evans, C. The use of penile prosthesis in the treatment of impotence. Brit J. Urol. 1998; 81: 591-598.
15. Freedman, A.L., Costa neto, F. Mehringer, C.M. and Rajfer J. Long term results of penile vein ligation for venous leakage. J. Urol. 1993; 149: 1301-1303.
16. Wespes, E., Corbusier A., Delcour, C. et al. Deep vein arterialization in vascular impotence. Brit J. Urol. 1989; 64: 535-540.
17. Burnett, A.L. The role of nitric oxide in the physiology of erection. Biol. Reprod. 1995; 52: 485-489.
18. Rajfer, J., Aronson, W.J. Bush, P.A. Dorey, F.J. and Ignarro L.J. Nitric oxide as a mediator of relaxation of the corpus caernosum in response to nonadrenergic, noncholinergic neurotransmission. N. Engl. J. Med. 1992; 326: 90-94.
19. Moreland, R.B., Goldstein, I. and Traish, A. Sildenafil, a novel inhibitor of phosphodiasterase type 5 in human corpus cavernosum smooth muscle cells. Life sci. 1998; 62: PL309-318.
20. Boolel, M., Allen, M.J., Ballard, S.A. et al. An orally active type cyclic GMP specific phosphodiasterase inhibitor for the treatment of penile erectile dysfuntion. Int. J. Impot. Res. 1996; 8: 47-52.
21. Rosen, R.C., Riley, A., Wagner, G., Osterloh, I.A., Kirkpatrick, J. and Mishra A. The international index of erectile function (11EF): A multidimentional scale for assessment of erectile function. Urology, 1997, 49: 822-830.
22. Chen, J., Wollman, Y., Chernichovsry, T. et al. Effect of oral administration of high dose nitric oxide donor L-arginine in men with organic erectile dysfunction: Results of a double blind randomized placebo controlled study. Bju International. 1999; 83: 269-273.
23. Kunelius, P., Hakkinen, J. and Lukkarinen, O. Is high dose yohimbine hydrochloride effective in the treatment of mixed type impotence? A prospective randomized controlled double blind crossover study. Urology. 1997; 49: 441-444.
24. Aytac, L.A., Mckinlay, J.B. and Krane, R.J. The likely worldwide increase in erectile dysfunction between 1995 and 2025, some possible policy consequences. Bju International. 1999; 84: 50-56.
25. Goldstein, I. Lue, T.F. and Padma-nathan H. Oral sildenafil in the treatment of erectile dysfunction. N. Engl. J. Med. 1998; 338: 1397-1404.
26. Spector, I.P. and Carey, M.P. Incidence and prevalence of sexual dysfunction: A critical view of the empirical literature. Arch. Sex. Bhav. 1990; 19: 389.
27. Eardley, I., Brook, J. Yates, P.K., Wulff, M.B. and Boolel, N. Sildenafil (Viagra), A novel oral treatment with rapid onset of action for penile erection dysfunction. Brit. J. Urol. 1997; 4: 66.
28. Lue T.F. and The sildenafil study group. A study of Sildenafil (Viagra) a new oral agent for the treatment of male erectile dysfunction. J. Urol. 1997; 157: 701.
29. Eardley, I. Morgan, R.J., Dinsmore, W.W. Pearson, J. Wulff, M.B. and Boolel, M. UK-92.480, a new oral therapy for erectile dysfunction. A double blind placebo controlled trial with treatment taken as required. J. Urol. 1996; 155: 495A.
30. Eardley, I. New oral therapies for the treatment of erectile dysfunction. Brit. J. Urol. 1998; 81: 122-127.
31. Boolell, M., Gepi - Atee, S., Ginger, J.C. and Allen, M.J. Sildenafil. A novel effective oral therapy for male erectile dysfunction. Brit. J. Urol. 1996; 78: 257-261.